HealthLynked Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HealthLynked Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.01M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $5.72M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $5.86M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $6.50M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.13M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.02M | Mar 31, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Sep 30, 2023 | $1.87M | Apr 1, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.28M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($6.13M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($1.01M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($8.82M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($10.41M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($5.76M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($5.53M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($5.79M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($2.58M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.38M) | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.11M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($4.68M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($4.15M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($8.66M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($5.33M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($3.07M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($3.21M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($2.97M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($1.79M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.17M) | Apr 2, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.04M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.04M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $3.62M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $4.58M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $4.93M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.06M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $2.92M | Mar 31, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.71M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($3.49M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($4.14M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($4.36M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($3.77M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($2.12M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($2.36M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($2.36M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($1.62M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($756.3K) | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $2.6K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.5K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $23.6K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $19.3K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $25.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $10.1K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $16.1K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $12.6K | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.70M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.22M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $4.28M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $4.58M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $10.69M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $8.03M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $2.55M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $427.4K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $439.8K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $329.5K | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.46M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $5.35M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $3.48M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $4.27M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $3.49M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.68M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $5.39M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.36M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.49M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.24M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.76M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($3.13M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $804.7K | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $314.5K | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $7.20M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $1.35M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | ($2.84M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | ($2.93M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | ($2.05M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | ($911.7K) | Apr 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $320.0K | Apr 1, 2024 |
| FY2024 | May 31, 2022 | $320.0K | Mar 31, 2025 |
| FY2022 | Dec 31, 2021 | $766.2K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.15M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $71.9K | Mar 31, 2021 |
| FY2019 | Apr 12, 2019 | $71.9K | Mar 30, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($50.54M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($48.16M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($42.03M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($41.02M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($32.21M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($21.78M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($16.03M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($10.50M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($4.71M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($2.12M) | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.1K | Mar 31, 2026 |
| FY2024 | Dec 31, 2024 | $76.2K | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $247.2K | Mar 31, 2025 |
| FY2021 | Dec 31, 2021 | $3.29M | Mar 31, 2022 |
| FY2021 | Dec 31, 2020 | $162.2K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $110.4K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $135.8K | Mar 30, 2020 |
| FY2019 | Dec 31, 2017 | $50.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $58.7K | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $29.8K | Apr 2, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.82M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 2.82M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 275.96M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 255.94M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 237.89M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 187.97M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 109.89M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 85.18M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 72.30M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 65.75M | Apr 2, 2018 |